Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

An attorney for Keith Middlebrook said they would appeal and called Magic Johnson, who testified during trial, "the biggest ...

San Francisco's Public Health Director Dr. Grant Colfax is stepping down after spending nearly six years as the city's ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

The European Commission (EC) has granted marketing authorisation under exceptional circumstances for InflaRx’s Gohibic ...

InflaRx (IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

San Francisco’s public health director, who oversaw the city’s responses to the COVID-19 pandemic and fentanyl crisis, ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...